New drug combo identified for liver cancer via CRISPR-Cas9 screen — ScienceDaily

A research team of LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has successfully repurposed an approved drug ifenprodil, a vasodilator, to be used in combination with the…